Saturday, April 20, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Autoimmune Bleeding Disorder Diagnosed After COVID Shots

bleeding disorder

Four cases of an autoimmune bleeding disorder known as acquired hemophilia (AHA) were diagnosed in Italy’s northern province of Reggio Emilia weeks after the individuals received Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) biologic. The report about these four cases was published in a letter to the editors of journal Thrombosis Research […]

NIH-Funded Study Found COVID-19 Shots Impact Menstrual Cycles

woman experiencing menstrual pain

A U.S. cohort study assessing the effect of COVID-19 shots on menstrual cycles was peer reviewed and published in the journal Obstetrics & Gynecology on Jan. 5, 20221 after many  women spoke out about changes to their menstrual cycles after receiving COVID shots. The U.S. National Institutes of Health (NIH) provided $1.6 million to fund […]

Hearing Loss and Tinnitus May Be Linked to COVID Vaccination

tinnitus

A new study published in the journal JAMA Otolaryngology-Head & Neck Surgery published on Feb. 24, 2022 has found a possible association between Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic and sudden sensorineural hearing loss (SSNHL). The retrospective cohort study of 2 ,602, 557 patients in Israel suggested a slight increased risk of SSNHL.1 […]

COVID Vaccine-Induced Myocarditis Cited by Medical Examiners in Death of Two Boys

grasping chest

Two adolescent boys, who suddenly passed away in Connecticut and Michigan within a week after receiving the second dose of Pfizer/BioNTech’s BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 vaccine, died due to myocarditis, according to a study published in the journal Archives of Pathology & Laboratory Medicine on Feb. 14 2022.1 The boys, […]

Pfizer Withdraws EUA Application for COVID Shot in India After Regulator Asks for Independent Safety Study

Pfizer's BNT162b2 biologic

Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic (developed in collaboration with Germany’s BioNTech) in India.1 Pfizer was the first pharmaceutical company to apply for an EUA to distribute a COVID biologic in India in 2021. However, India’s regulatory agency […]

Search in Site

To search in site, type your keyword and hit enter

Search